CMS Finalizes Telehealth, ESRD, Star Ratings, Reinsurance Policies for 2021

June 4

Finalizing a series of policies just before the 2021 bid deadline, CMS on May 22 said it will address remaining proposals from its February proposed rule at a later date (RMA 2/20/20, p. 1).

CMS finalized a proposal to count telehealth providers in certain specialty areas (e.g., dermatology, psychiatry, cardiology, ophthalmology) toward meeting CMS network adequacy standards. The agency also lowered the required percentage of rural beneficiaries who must reside within the maximum time and distance standards from 90% to 85%.

0
0 Comments
© 2021 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_274078056.jpg
November 18

Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg
November 18

Given COVID Surge, Humana Deviates From Peers With Lower Guidance

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/WordPress-Featured-Image-radar-on-medicare-advantage-MedPAC-Reforms-to-Part-D-LIS-Could-Produce-Savings.jpg
November 18

Clover Health Struggles to Contain Medical Costs for MA Members

READ MORE
directory-of-health-plans-test-drive-directory-of-health-plans-ad

The Latest

Premium Categories

meet-the-expert-webinar-navigating-the-complex-us-payer-landscape-to-grow-your-business-ad

Meet Our Reporters

Tags

AIS's Directory of Health Plans Behavioral Health Benefit Design Benefit Management Biosimilars Cell and Gene Therapies Consumer Engagement COVID Data & Analytics Drug Approvals Drug Pricing Dual Eligibles Employer Group Health Plans Executive Compensation FDA FDA Specialty Approvals Fee-for-service Medicare Financial Results Infographics Infusion Therapy legislation & regulation Managed Medicaid Market access Medical Costs Medicare Advantage Medicare Advantage Rx Drug Medicare Part D Membership Growth Mergers & Acquisitions News Briefs Oncology Payer Portrait PBMs; Pharmacy Benefit Manager Policy & Politics Premiums Reimbursement Site of Care Management Social Determinants of Health Specialty Drugs Stock Performance telehealth Value-based Arrangements

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today